ArticleClinical transplantation2026
Posttraumatic Stress Symptoms in Patients on Ventricular Assist Device Support: Something to Worry About?
Article in Clinical transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPsychosocial outcome in ventricular assist device (VAD) patients continues to merit evaluation including posttraumatic stress symptoms (PTSS).
methodsA cross-sectional multicenter study collected data from 265 VAD patients, mean age was 59 ± 11yrs, 88% (N = 234) were male. Standardized PRO measures were applied; PTSS was assessed with the Breslau scale, supplemented by open-ended questions on "any traumatizing life events".
resultsThe weighted mean prevalence for patients reporting "any traumatizing event" was 43.0% (95% CI 37.0-49.2); prevalence for PTSS was 3.8% (95% CI 1.82-6.83). Traumatizing events were categorized into non-heart-related versus heart-related (both n = 57; 50%); heart surgery (n = 16) was most prominent. Oral intake of prescribed psychotropics (12.5%) was significantly higher in those with non-heart-related events (28.1% vs. 7.0%; p = 0.006). Female gender was associated with an OR of 1.703 (95%CI: 1.217-2.382; p = 0.002) for HADS
conclusionA substantial proportion of VAD patients may have experienced traumatizing events; heart surgery was reported most prominently, may diminish the success of implantation, lead to PTSS, and warrants routine clinical screening of patients following VAD implantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.